57894-071Level 3
Simponi (golimumab)
**Product type:** Human Prescription Drug
**Active ingredient:** GOLIMUMAB
**Strength:** 100 mg/mL
**Dosage form:** Injection, Solution
**Route:** Subcutaneous
**Labeler:** Janssen Biotech, Inc.
**Marketing category:** BLA (BLA125289)
**Pharmacologic class:** Tumor Necrosis Factor Blocker [EPC], Tumor Necrosis Factor Receptor Blocking Activity [MoA]
GET
/api/v1/systems/ndc_fda/nodes/57894-071Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.